Search - tctmd.com

Displaying 321 - 335 of 335

Sort: Relevancy | Date

Presentation TCT 2013

Drug-Coated Balloons in Patients with Diabetes: A Specific Niche?

Presenter: Christoph Naber

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data(2)

Presenter: Franz Kleber

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data

Presenter: Franz Kleber

October 31, 2013

Presentation TCT 2013

Coronary Drug-Coated Balloons in De Novo Lesions: What are the Technical and Safety Considerations That Haven't Been Addressed?

Presenter: Bernardo Cortese

October 31, 2013

Presentation TCT 2013

Atherectomy and Drug-Coated Balloons: Device Selection, Technical Pitfalls and Available Data

Presenter: Erwin Blessing

October 31, 2013

Presentation TCT 2013

Acute Coronary Syndromes Including STEMI: Is There a Need and a Role for Drug-Coated Balloons?

Presenter: Pieter Stella

October 31, 2013

News Conference News TCT 2013

Drug-coated Balloons May Become Standard of Care in ISR

October 31, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

News Conference News TCT 2013

Paclitaxel-Coated Balloons Show Promise in Two Studies

October 29, 2013

Presentation TCT 2013

Drug-coated Balloons for Bifurcation Lesions: Rationale, Practice, and Evidence

Presenter: Kenneth Chin

October 28, 2013

Presentation TCT 2013

Drug-Coated Balloons in the Management of SFA In-Stent Restenosis: The FAIR Randomized Trial

Presenter: Thomas Zeller

October 27, 2013

Presentation TCT 2012

Current and Future Clinical Applications of Drug-Coated Balloons: From Bench to Bedside

Presenter: Bruno Scheller

October 26, 2012

Presentation TCT 2012

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Presenter: Eugenio Stabile

October 22, 2012

Presentation TCT 2012

Drug-Coated Balloons and Atherectomy: Additive, Synergistic, or Without Advantage?

Presenter: Luigi Salemme

October 22, 2012

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

Advertisement

Drug-Coated Balloons in Patients with Diabetes: A Specific Niche?

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data(2)

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data

Coronary Drug-Coated Balloons in De Novo Lesions: What are the Technical and Safety Considerations That Haven't Been Addressed?

Atherectomy and Drug-Coated Balloons: Device Selection, Technical Pitfalls and Available Data

Acute Coronary Syndromes Including STEMI: Is There a Need and a Role for Drug-Coated Balloons?

Drug-coated Balloons May Become Standard of Care in ISR

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

Paclitaxel-Coated Balloons Show Promise in Two Studies

Drug-coated Balloons for Bifurcation Lesions: Rationale, Practice, and Evidence

Drug-Coated Balloons in the Management of SFA In-Stent Restenosis: The FAIR Randomized Trial

Current and Future Clinical Applications of Drug-Coated Balloons: From Bench to Bedside

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Drug-Coated Balloons and Atherectomy: Additive, Synergistic, or Without Advantage?

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content